Pfizer Offers Its RNA COVID-19 Vaccine To India At 'No Profit' Price

American pharmaceutical company Pfizer Inc. on April 22 offered to provide its RNA (mRNA) COVID-19 vaccine to India at a 'not for profit' price. Reportedly, the offer is to adopt a distinct pricing structure for different countries. The company claims to make the vaccine available to all income sections of people as they are committed to work towards equitable and affordable access for the vaccine around the world.